What are the indications for albendazole?

Indications for Albendazole

Albendazole is FDA-approved for two primary indications: parenchymal neurocysticercosis caused by larval forms of Taenia solium and cystic hydatid disease (liver, lung, peritoneum) caused by Echinococcus granulosus. 1

FDA-Approved Indications

1. Parenchymal Neurocysticercosis

• Treatment of active lesions caused by larval forms of the pork tapeworm (Taenia solium) 1
• Dosing: 15 mg/kg/day divided twice daily (maximum 1200 mg/day) for 8-30 days, taken with food 2, 1
• For 1-2 viable cysts: albendazole monotherapy for 10-14 days 2
• For >2 viable cysts: combination therapy with albendazole (15 mg/kg/day) plus praziquantel (50 mg/kg/day) for 10-14 days 2

2. Cystic Hydatid Disease

• Treatment of cysts in liver, lung, and peritoneum caused by Echinococcus granulosus 1
• Dosing: Patients ≥60 kg receive 400 mg twice daily; <60 kg receive 15 mg/kg/day divided twice daily (maximum 800 mg/day) 1
• Treatment consists of 28-day cycles followed by 14-day drug-free intervals, typically for 3 cycles 1

Broader Clinical Uses (Off-Label but Evidence-Based)

Intestinal Nematode Infections

Albendazole demonstrates excellent efficacy for common intestinal parasites 3, 4:

• Hookworm (Necator americanus, Ancylostoma duodenale): 78% overall cure rate, with 92% for A. duodenale 4
• Ascariasis (Ascaris lumbricoides): 95% cure rate 4
• Pinworm (Enterobius vermicularis): 98% cure rate 4
• Strongyloidiasis: 62% cure rate with 400 mg daily for 3 days 4
• Whipworm (Trichuris trichiura): 48% cure rate (lower efficacy) 4

Intestinal Cestode Infections

• Taeniasis (Taenia spp.): 85% cure rate with 400 mg daily for 3 days 4
• Hymenolepiasis (Hymenolepis nana): 68% cure rate 4

Tissue Parasitic Infections

Albendazole shows therapeutic effects against 3:

• Visceral, ocular, neural, and cutaneous larva migrans
• Trichinosis, capillariasis, angiostrongyliasis, gnathostomiasis
• Subcutaneous cysticercosis and echinococcosis

Filarial Infections

• Used in combination with ivermectin or diethylcarbamazine for lymphatic filariasis elimination programs 3, 5
• Triple therapy (IDA: ivermectin, diethylcarbamazine, albendazole) now recommended by WHO for mass drug administration 5
• Shows microfilaricidal activity against Loa loa with 82% reduction in microfilaremia after 30 days 6

Protozoan Infections

• Microsporidiosis (Encephalitozoon intestinalis): 400 mg twice daily for 3 weeks achieves parasitologic clearance in AIDS patients 7
• Giardiasis, cryptosporidiosis (variable efficacy) 3

Critical Safety Monitoring Requirements

For treatment courses >14 days, mandatory monitoring includes 2, 1:

• Hepatotoxicity monitoring: Check liver enzymes before each cycle and every 2 weeks during therapy; discontinue if clinically significant elevations occur
• Bone marrow suppression: Monitor complete blood counts at cycle initiation and every 2 weeks; fatalities have occurred from myelosuppression 1
• Leukopenia surveillance: Particularly important with prolonged therapy 2

Essential Pre-Treatment Considerations

Before Initiating Therapy for Neurocysticercosis:

1. Fundoscopic examination mandatory to rule out retinal cysticercosis (risk of retinal damage) 2
2. Screen for Strongyloides stercoralis if prolonged corticosteroids anticipated (hyperinfection risk) 2
3. Latent tuberculosis screening if prolonged corticosteroids likely needed 2
4. Pregnancy testing for females of reproductive potential (embryo-fetal toxicity risk) 1

Contraindications to Antiparasitic Therapy:

• Untreated hydrocephalus or diffuse cerebral edema—manage elevated intracranial pressure first, not antiparasitic treatment 2
• Known hypersensitivity to benzimidazole compounds 1

Common Pitfalls to Avoid

• Drug resistance emerging in hookworms, Trichuris trichiura, possibly Ascaris lumbricoides, and Giardia 3
• Neurologic symptoms may worsen initially in neurocysticercosis patients due to inflammatory response; concurrent corticosteroids and anticonvulsants are essential 1
• Inadequate treatment duration for toxocariasis can lead to relapse; some cases require 8 weeks rather than standard 4 weeks 8
• Food requirement: Albendazole must be taken with food to optimize absorption 2, 1